int230-6
intensity therapeutics
[]
don t miss the poster on dual-cancer activity of int230-6 for #solidtumors involving giles whalen. when the agent is given intratumorally alone or with pem, #immunecells rush in reducing #tumor size. study patients live longer than expected. #asco2022 
Advancing #CancerResearch with hallmark in basic science | Affiliated with @UMassChan